News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
AMA ends bundled maternity billing in 2027
Healthcare's last major bundled payment system breaks into itemized charges, creating new cost exposure for employers.
Aderant CTO Andy Hoyt exits after AI platform launch
Legal software vendor confirms leadership departure 18 months after Hoyt joined to build its AI roadmap.
Pinsent Masons hires AI adoption officer from BCLP
International law firm creates dedicated role to manage vendor tool selection as AI promises multiply weekly.
Lilly and Gilead drive 2026 pharma M&A surge past 2025 levels
Deal volume in 2026 already exceeds last year's total, with cancer and autoimmune therapies driving acquisition activity.
Novo's Wegovy pill beats Q1 sales estimates by 95%
The oral GLP-1 drug hit $354M in first-quarter sales, nearly double analyst expectations, helping Novo narrow its projected 2026 decline.
Biotech layoffs slow to 40 rounds in four months vs 50 late 2025
Industry job cuts decelerated but familiar pressures persist: drug failures, FDA rejections, and patent cliffs driving reductions.
Indian regulator seizes $38K alkaline water over banned additive
FSSAI seized stocks after lab tests confirmed fulvic acid, a non-permitted ingredient, was deliberately added to alkaline water products.
Two Indians test positive for hantavirus on cruise ship
India's NIV says isolated cases pose no immediate public health threat as virus rarely spreads between humans unlike COVID-19.
Scientists isolate human antibodies that neutralize measles virus
La Jolla researchers found antibodies from vaccinated woman that cut viral load 500-fold in rodent trials, offering first potential treatment for exposed patients.
India tracks hantavirus outbreak on cruise ship with 2 citizens aboard
Health Ministry monitors MV Hondius outbreak that killed 3, infected 5 more, with two asymptomatic Indians under observation.
WHO confirms 6 hantavirus cases, 3 deaths on cruise ship
Six of eight suspected hantavirus cases confirmed on cruise ship with 38% fatality rate, but WHO rates global risk as low.
Bright Uro gets FDA clearance for Glean abdominal sensor
Medical device company secures regulatory approval for abdominal monitoring sensor, clearing path to U.S. market deployment.